Increased levels of PLG were furthermore associated with increased risk of AF, IBD, CD, Alzheimer’s disease (Fig. 6) as well as lipids, and increased SBP (Fig. 6), but these effects may not be observed therapeutically because tPA is given as a single dose in acute MI and ischaemic stroke. This evidence concerns the gene PLAT and Alzheimer disease.